<http://webisa.webdatacommons.org/prov/502276622>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/349946711> .
<http://webisa.webdatacommons.org/349946711>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/349946711>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<google.com> .
<http://webisa.webdatacommons.org/349946711>	<http://www.w3.org/ns/prov#value>	"e 8 antigen; IGIV (immune globulin intravenous)US7045131Mar 7, 2002May 16, 2006Inhibitex, Inc.For passive immunization of patients infected with or susceptible to infection from Staphylococcus bacteria such as S.aureus and S.epidermidisUS7157443Dec 6, 2002Jan 2, 2007Merck & Co., Inc.High molecular weight intracellular adhesin antigen; induction immunology responseUS7250494Dec 20, 2002Jul 31, 2007B" .